K Cin 500mg Amikacin Sulphate Injection

Starts From: 750.00

K-Cin 500 mg/2 ml Injection (Amikacin Sulphate) is a broad-spectrum aminoglycoside antibiotic, widely used for severe infections including septicemia, respiratory, urinary, abdominal, bone, and skin infections, particularly in hospital-acquired and drug-resistant cases.

  Buy via WhatsApp

Description

Strength 500 mg/ 2ml
Brand Name K Cin
Manufacturer Intelico Pharmaceuticals Pvt. Ltd
Packaging Type Box
Usage/Application To Treat Serious Bacterial Infections In Many Different Parts Of The Body.
Shelf Life 24 Months
Composition Amikacin Sulphate
Form Injection
Product’s Details:

  • K-Cin Amikacin Sulphate Injection is a potent aminoglycoside antibiotic used to manage life-threatening bacterial infections. It works by inhibiting protein synthesis in bacteria, leading to their destruction. Administered via intramuscular or intravenous routes, K-Cin is reserved for serious infections where other antibiotics may not be effective. Due to its nephrotoxic and ototoxic potential, dosage adjustment and monitoring are crucial in patients with renal impairment.
  • Indications:
    • Severe infections of the respiratory tract, urinary tract, bones, joints, skin, and soft tissues
    • Intra-abdominal infections
    • Septicemia (blood infections)
    • Post-surgical infections
    • Hospital-acquired infections
    • Infections caused by multi-drug resistant Gram-negative bacilli
  • Precautions:
    • Use with caution in patients with kidney impairment or hearing disorders
    • Avoid use during pregnancy unless absolutely necessary
    • Regular monitoring of renal function and drug levels may be required
  • Possible Side Effects:
    • Nephrotoxicity (kidney damage)
    • Ototoxicity (hearing loss)
    • Allergic reactions
    • Injection site pain
  • Storage:
    • Store below 25 °C
    • Protect from light
    • Do not freeze

Reviews

There are no reviews yet.

Be the first to review “K Cin 500mg Amikacin Sulphate Injection”

Your email address will not be published. Required fields are marked *